750511000001102: Bendroflumethiazide 2.5mg tablets (Kent Pharma (UK) Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Bendroflumethiazide 2.5mg tablets (Kent Pharma (UK) Ltd)
\UK product\Virtual medicinal product\Product containing precisely bendroflumethiazide 2.5 milligram/1 each conventional release oral tablet\Bendroflumethiazide 2.5mg tablets (Kent Pharma (UK) Ltd)
\UK product\Virtual therapeutic moiety\Bendroflumethiazide\Product containing only bendroflumethiazide in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 2.5 milligram/1 each conventional release oral tablet\Bendroflumethiazide 2.5mg tablets (Kent Pharma (UK) Ltd)
\UK product\Virtual therapeutic moiety\Bendroflumethiazide\Product containing precisely bendroflumethiazide 2.5 milligram/1 each conventional release oral tablet\Bendroflumethiazide 2.5mg tablets (Kent Pharma (UK) Ltd)

\Medicinal product\Medicinal product categorized by structure\Product containing benzothiadiazine\Product containing bendroflumethiazide\Bendroflumethiazide\Product containing only bendroflumethiazide in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 2.5 milligram/1 each conventional release oral tablet\Bendroflumethiazide 2.5mg tablets (Kent Pharma (UK) Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing benzothiadiazine\Product containing bendroflumethiazide\Bendroflumethiazide\Product containing precisely bendroflumethiazide 2.5 milligram/1 each conventional release oral tablet\Bendroflumethiazide 2.5mg tablets (Kent Pharma (UK) Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing benzothiadiazine\Product containing bendroflumethiazide\Product containing bendroflumethiazide in oral dose form (medicinal product form)\Product containing only bendroflumethiazide in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 2.5 milligram/1 each conventional release oral tablet\Bendroflumethiazide 2.5mg tablets (Kent Pharma (UK) Ltd)
\Medicinal product\Medicinal product categorized by structure\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing bendroflumethiazide\Bendroflumethiazide\Product containing only bendroflumethiazide in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 2.5 milligram/1 each conventional release oral tablet\Bendroflumethiazide 2.5mg tablets (Kent Pharma (UK) Ltd)
\Medicinal product\Medicinal product categorized by structure\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing bendroflumethiazide\Bendroflumethiazide\Product containing precisely bendroflumethiazide 2.5 milligram/1 each conventional release oral tablet\Bendroflumethiazide 2.5mg tablets (Kent Pharma (UK) Ltd)
\Medicinal product\Medicinal product categorized by structure\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing bendroflumethiazide\Product containing bendroflumethiazide in oral dose form (medicinal product form)\Product containing only bendroflumethiazide in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 2.5 milligram/1 each conventional release oral tablet\Bendroflumethiazide 2.5mg tablets (Kent Pharma (UK) Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as diuretic (product)\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing bendroflumethiazide\Bendroflumethiazide\Product containing only bendroflumethiazide in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 2.5 milligram/1 each conventional release oral tablet\Bendroflumethiazide 2.5mg tablets (Kent Pharma (UK) Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as diuretic (product)\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing bendroflumethiazide\Bendroflumethiazide\Product containing precisely bendroflumethiazide 2.5 milligram/1 each conventional release oral tablet\Bendroflumethiazide 2.5mg tablets (Kent Pharma (UK) Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as diuretic (product)\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing bendroflumethiazide\Product containing bendroflumethiazide in oral dose form (medicinal product form)\Product containing only bendroflumethiazide in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 2.5 milligram/1 each conventional release oral tablet\Bendroflumethiazide 2.5mg tablets (Kent Pharma (UK) Ltd)
\Medicinal product\Product manufactured as oral dose form\Product containing bendroflumethiazide in oral dose form (medicinal product form)\Product containing only bendroflumethiazide in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 2.5 milligram/1 each conventional release oral tablet\Bendroflumethiazide 2.5mg tablets (Kent Pharma (UK) Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

1848461000001118 Bendroflumethiazide 2.5mg tablets (Kent Pharma (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1848471000001111 Bendroflumethiazide 2.5mg tablets (Kent Pharma (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Bendroflumethiazide 2.5mg tablets (Kent Pharma (UK) Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Bendroflumethiazide 2.5mg tablets (Kent Pharma (UK) Ltd)	Is a	Product containing precisely bendroflumethiazide 2.5 milligram/1 each conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Bendroflumethiazide 2.5mg tablets (Kent Pharma (UK) Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available	true	Inferred relationship	Existential restriction modifier
Bendroflumethiazide 2.5mg tablets (Kent Pharma (UK) Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Bendroflumethiazide 2.5mg tablets (Kent Pharma (UK) Ltd)	Has active ingredient	Bendroflumethiazide	false	Inferred relationship	Existential restriction modifier
Bendroflumethiazide 2.5mg tablets (Kent Pharma (UK) Ltd)	Has active ingredient	Bendrofluazide - chemical	false	Inferred relationship	Existential restriction modifier
Bendroflumethiazide 2.5mg tablets (Kent Pharma (UK) Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Bendroflumethiazide 2.5mg tablets (Kent Pharma (UK) Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Bendroflumethiazide 2.5mg tablets (Kent Pharma (UK) Ltd)	Has manufactured dose form	Conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Bendroflumethiazide 2.5mg tablets (Kent Pharma (UK) Ltd)	Has specific active ingredient	Bendroflumethiazide	true	Inferred relationship	Existential restriction modifier
Bendroflumethiazide 2.5mg tablets (Kent Pharma (UK) Ltd)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Bendroflumethiazide 2.5mg tablets (Kent Pharma (UK) Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Bendroflumethiazide 2.5mg tablets (Kent Pharma (UK) Ltd) 28 tablet	Is pack of	False	Bendroflumethiazide 2.5mg tablets (Kent Pharma (UK) Ltd)	Inferred relationship	Existential restriction modifier
Bendroflumethiazide 2.5mg tablets (Kent Pharma (UK) Ltd) 500 tablet	Is pack of	False	Bendroflumethiazide 2.5mg tablets (Kent Pharma (UK) Ltd)	Inferred relationship	Existential restriction modifier
Bendroflumethiazide 2.5mg tablets (Kent Pharma (UK) Ltd) 28 tablet	Has AMP	True	Bendroflumethiazide 2.5mg tablets (Kent Pharma (UK) Ltd)	Inferred relationship	Existential restriction modifier
Bendroflumethiazide 2.5mg tablets (Kent Pharma (UK) Ltd) 500 tablet	Has AMP	True	Bendroflumethiazide 2.5mg tablets (Kent Pharma (UK) Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1848461000001118	Bendroflumethiazide 2.5mg tablets (Kent Pharma (UK) Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
1848471000001111	Bendroflumethiazide 2.5mg tablets (Kent Pharma (UK) Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module